Matches in SemOpenAlex for { <https://semopenalex.org/work/W3092562316> ?p ?o ?g. }
- W3092562316 endingPage "3752" @default.
- W3092562316 startingPage "3713" @default.
- W3092562316 abstract "Background: Prostate cancer is one of the most common cancers worldwide, with approximately 1.1 million cases diagnosed annually. The rapid development of molecular imaging has facilitated greater structural understanding which can help formulate novel combination therapeutic regimens and more accurate diagnosis avoiding unnecessary prostate biopsies. This accumulated knowledge also provides greater understanding into aggressive stages of the disease and tumour recurrence. Recently, much progress has been made on developing peptidomimetic-based inhibitors as promising candidates to effectively bind to the prostate-specific membrane antigen (PSMA) which is expressed by prostate cancer cells. Objective: In this review, recent advances covering small-molecule and peptide-based PSMA inhibitors will be extensively reviewed, providing a base for the rational design of future PSMA inhibitors. Method: Herein, the literature on selected PSMA inhibitors that have been developed from 1996 to 2020 were reviewed, emphasizing recent synthetic advances and chemical strategies whilst highlighting therapeutic potential and drawbacks of each inhibitor. Results: Synthesized inhibitors presented in this review demonstrate the clinical application of certain PSMA inhibitors, exhibited in vitro and in vivo. Conclusion: This review highlights the clinical potential of PSMA inhibitors, analyzing the advantages and setbacks of the chemical synthetic methodologies utilized, setting precedence for the discovery of novel PSMA inhibitors for future clinical applications." @default.
- W3092562316 created "2020-10-15" @default.
- W3092562316 creator A5014054134 @default.
- W3092562316 creator A5043992105 @default.
- W3092562316 creator A5048392040 @default.
- W3092562316 creator A5056627966 @default.
- W3092562316 date "2021-06-01" @default.
- W3092562316 modified "2023-10-16" @default.
- W3092562316 title "Evolution of Peptide-Based Prostate-Specific Membrane Antigen (PSMA) Inhibitors: An Approach to Novel Prostate Cancer Therapeutics" @default.
- W3092562316 cites W1511122106 @default.
- W3092562316 cites W1602402196 @default.
- W3092562316 cites W1756852897 @default.
- W3092562316 cites W1786020367 @default.
- W3092562316 cites W1831395375 @default.
- W3092562316 cites W1967865298 @default.
- W3092562316 cites W1973269553 @default.
- W3092562316 cites W1977812789 @default.
- W3092562316 cites W1980612042 @default.
- W3092562316 cites W1981293730 @default.
- W3092562316 cites W1982551773 @default.
- W3092562316 cites W1983215652 @default.
- W3092562316 cites W1983998585 @default.
- W3092562316 cites W1984513787 @default.
- W3092562316 cites W1988876924 @default.
- W3092562316 cites W1989208232 @default.
- W3092562316 cites W1989481955 @default.
- W3092562316 cites W1990288109 @default.
- W3092562316 cites W1992868992 @default.
- W3092562316 cites W2002222551 @default.
- W3092562316 cites W2004736778 @default.
- W3092562316 cites W2004803702 @default.
- W3092562316 cites W2005814589 @default.
- W3092562316 cites W2006664751 @default.
- W3092562316 cites W2010529363 @default.
- W3092562316 cites W2012298966 @default.
- W3092562316 cites W2012457056 @default.
- W3092562316 cites W2014999922 @default.
- W3092562316 cites W2016368943 @default.
- W3092562316 cites W2021372044 @default.
- W3092562316 cites W2023735230 @default.
- W3092562316 cites W2024744319 @default.
- W3092562316 cites W2028869260 @default.
- W3092562316 cites W2036808326 @default.
- W3092562316 cites W2038171733 @default.
- W3092562316 cites W2038578630 @default.
- W3092562316 cites W2040974331 @default.
- W3092562316 cites W2051403632 @default.
- W3092562316 cites W2051611532 @default.
- W3092562316 cites W2052933378 @default.
- W3092562316 cites W2053978050 @default.
- W3092562316 cites W2057515909 @default.
- W3092562316 cites W2063369647 @default.
- W3092562316 cites W2063649715 @default.
- W3092562316 cites W2065442902 @default.
- W3092562316 cites W2067602854 @default.
- W3092562316 cites W2075661864 @default.
- W3092562316 cites W2081758723 @default.
- W3092562316 cites W2081982238 @default.
- W3092562316 cites W2084834351 @default.
- W3092562316 cites W2088897416 @default.
- W3092562316 cites W2102600287 @default.
- W3092562316 cites W2105537697 @default.
- W3092562316 cites W2115596815 @default.
- W3092562316 cites W2116915766 @default.
- W3092562316 cites W2120171756 @default.
- W3092562316 cites W2125363072 @default.
- W3092562316 cites W2128349096 @default.
- W3092562316 cites W2130600512 @default.
- W3092562316 cites W2133777928 @default.
- W3092562316 cites W2134019417 @default.
- W3092562316 cites W2136073863 @default.
- W3092562316 cites W2136976588 @default.
- W3092562316 cites W2144372816 @default.
- W3092562316 cites W2155421560 @default.
- W3092562316 cites W2161377113 @default.
- W3092562316 cites W2219927033 @default.
- W3092562316 cites W2234017926 @default.
- W3092562316 cites W2277107147 @default.
- W3092562316 cites W2279794187 @default.
- W3092562316 cites W2288548215 @default.
- W3092562316 cites W2320556745 @default.
- W3092562316 cites W2322038821 @default.
- W3092562316 cites W2340433154 @default.
- W3092562316 cites W2403992157 @default.
- W3092562316 cites W2466422293 @default.
- W3092562316 cites W2473278896 @default.
- W3092562316 cites W2525793430 @default.
- W3092562316 cites W2534848937 @default.
- W3092562316 cites W2575425332 @default.
- W3092562316 cites W2582295064 @default.
- W3092562316 cites W2611673620 @default.
- W3092562316 cites W2884452804 @default.
- W3092562316 cites W2886127930 @default.
- W3092562316 cites W2902011700 @default.
- W3092562316 cites W2910322053 @default.
- W3092562316 cites W2917270564 @default.
- W3092562316 cites W2927062841 @default.
- W3092562316 cites W2942649812 @default.